Washington [US], August 11 (ANI): According to researchers at Johns Hopkins Medicine, an experimental dendrimer nanoparticle medication called OP-101 significantly lowered the risk of death and the need for a ventilator in a study of 24 seriously ill patients hospitalized with COVID-19.
Washington [US], August 11 (ANI): According to researchers at Johns Hopkins Medicine, an experimental dendrimer nanoparticle medication called OP-101 significantly lowered the risk of death and the need for a ventilator in a study of 24 seriously ill patients hospitalized with COVID-19.
\
\
